Trials / Completed
CompletedNCT00238654
A Study to Evaluate Readiness to Self-inject on Adherence and Compliance to Copaxone® Therapy
A Multicenter, Open-Label, Two-Arm Prospective Study to Evaluate the Impact of Patient Readiness to Self-Inject on Outcomes When Using the Copaxone® Prefilled Syringes [The "READY" Trial]
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 257 (actual)
- Sponsor
- Teva Neuroscience, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study has patients responding to two sets of surveys that will tell their doctor or nurse about their readiness to begin self-injection. In addition, patients will have their self-injection observed and evaluated on up to three visits
Conditions
Timeline
- Start date
- 2003-05-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2005-10-13
- Last updated
- 2011-04-12
Source: ClinicalTrials.gov record NCT00238654. Inclusion in this directory is not an endorsement.